| Cardiovascular Risk Management |
1 |
1 |
| Cardiometabolic Risk Factors |
0 |
0.95 |
| Hypertension |
0 |
0.89 |
| Cerebrovascular Accident |
0 |
0.68 |
| Thromboembolism |
0 |
0.57 |
| Heart |
0 |
0.55 |
| Platelet Count |
0 |
0.55 |
| Coronary Artery Disease (CAD) |
0 |
0.54 |
| Platelet Reactivity |
0 |
0.44 |
| Blood |
0 |
0.41 |
| Prediabetes |
0 |
0.28 |
| Thrombosis |
0 |
0.28 |
| Type 2 Diabetes Mellitus |
0 |
0.28 |
| Receptors |
0 |
0.21 |
| Patient Safety |
0 |
0.14 |
| Stroke Risk |
0 |
0.14 |
| Genomic Medicine |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Obesity |
0 |
0.09 |
| Adverse Effects |
0 |
0.07 |
| Artery |
0 |
0.07 |
| Cardiovascular disease |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Exercise |
0 |
0.07 |
| Genetics |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Massachusetts |
0 |
0.07 |
| Metabolism |
0 |
0.07 |
| New York |
0 |
0.07 |
| Nutrition |
0 |
0.07 |
| Ohio |
0 |
0.07 |
| Preventive Medicine |
0 |
0.07 |
| Virginia |
0 |
0.07 |